Racura Oncology’s lead drug candidate RC220 has cleared an important regulatory hurdle after receiving governance approval from Monash Health to start a phase I clinical trial in patients with ...
Respiratory illnesses such as COVID-19 and influenza are usually thought of as short-term infections that cause fever, cough, ...
Over the last two years, research has improved the understanding and treatment of disease. Using tools such as gene editing, ...